As of Nov 25
| +0.16 / +2.21%|
The 1 analysts offering 12-month price forecasts for ChemoCentryx Inc have a median target of 13.00, with a high estimate of 13.00 and a low estimate of 13.00. The median estimate represents a +75.68% increase from the last price of 7.40.
The current consensus among 2 polled investment analysts is to Buy stock in ChemoCentryx Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.